Four risk prediction models have been shown to accurately select the highest risk smokers for lung cancer screening. READ MORE
A recent study identified substantial barriers to standard-of-care therapy for limited-stage small cell lung cancer, including government insurance coverage.
Adjuvant EGFR TKI treatment for patients with EGFR-mutant NSCLC after complete resection offers a significant disease-free survival advantage, according to a recent meta-analysis.
Vaccine-based immunotherapy after surgery or radiotherapy did not increase survival in patients with localized non-small-cell lung cancer, according to a recent meta-analysis.
Upregulation of a specific protein may be an indicator of radiation resistance in patients with resected non-small cell lung cancer who received radiotherapy.